Worldmed Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 11-12-2024
- Paid Up Capital ₹ 1.00 M
as on 11-12-2024
- Company Age 13 Year, 2 Months
- Last Filing with ROC 31 Mar 2020
- Open Charges ₹ 3.50 M
as on 11-12-2024
- Revenue -66.85%
(FY 2020)
- Profit -113.16%
(FY 2020)
- Ebitda -209.43%
(FY 2020)
- Net Worth -725.49%
(FY 2020)
- Total Assets 14.82%
(FY 2020)
About Worldmed Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2020. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹3.50 M.
Rajarajeswari Appala, Kiran Chandramouli, and Veni Mocherla serve as directors at the Company.
- CIN/LLPIN
U24232TG2011PTC077033
- Company No.
077033
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Oct 2011
- Date of AGM
30 Dec 2020
- Date of Balance Sheet
31 Mar 2020
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Worldmed Life Sciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Veni Mocherla  | Additional Director | 16-Oct-2018 | Current |
| Rajarajeswari Appala | Additional Director | 18-Nov-2013 | Current |
| Kiran Chandramouli | Additional Director | 16-Oct-2018 | Current |
Financial Performance and Corporate Structure Insights of Worldmed Life Sciences.
Worldmed Life Sciences Private Limited, for the financial year ended 2020, experienced significant reduction in revenue, with a 66.85% decrease. The company also saw a substantial fall in profitability, with a 113.16% decrease in profit. The company's net worth observed a substantial decline by a decrease of 725.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Worldmed Life Sciences?
In 2018, Worldmed Life Sciences had a promoter holding of 50.00% and a public holding of 50.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Canara Bank Creation Date: 15 May 2014 | ₹3.50 M | Open |
How Many Employees Work at Worldmed Life Sciences?
Unlock and access historical data on people associated with Worldmed Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Worldmed Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Worldmed Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
